<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
September 25, 1996
ANIKA RESEARCH, INC.
(Exact name of registrant as specified in charter)
MASSACHUSETTS
(State or Other Jurisdiction of Incorporation)
000-21326 04-3145961
(Commission file number) (IRS employer identification
number)
236 WEST CUMMINGS PARK, WOBURN, MASSACHUSETTS 01801
(Address of principal executive offices) (Zip code)
(617) 932-6616
(Registrant's telephone number, including area code)
This document contains a total of 3 pages.
<PAGE>
ITEM 5. OTHER EVENTS
------------
On September 25, 1996, the Board of Directors of Anika Research, Inc. (the
"Company") announced that the Company has received a Commumautee European (CE)
mark registration to market its ORTHOVISC(R) product.
The Company also announced that effective September 26, 1996, J. Melville
Engle will fill the previously vacant post of president and chief executive
officer.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ANIKA RESEARCH, INC.
Date: September 27, 1996 By: /s/ Sean F. Moran
------------------------------
Sean F. Moran
Vice President of Finance and
Treasurer (Principal Financial
and Accounting Officer)
3
